ARCA Biopharma Inc (NASDAQ:ABIO)
| 2.50 Delayed Data As of 3:59pm ET |  +0.15 / +6.38%Today’s Change | 2.15 Today|||52-Week Range 3.36 | -12.28% Year-to-Date |
Latest ABIO News | Press Releases
No recent news for ARCA Biopharma Inc.
Today’s Trading
| Previous close | 2.35 |
| Today’s open | 2.45 |
| Day’s range | 2.40 - 2.50 |
| Volume | 26,797 |
| Average volume (3 months) | 35,846 |
| Market cap | $21.7M |
| Dividend yield | -- |
Data as of 3:59pm ET, 06/26/2017
Growth & Valuation
| Earnings growth (last year) | +44.68% |
| Earnings growth (this year) | +28.57% |
| Earnings growth (next 5 years) | +30.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.56 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AVIRAviragen Therapeutic... | 0.00 | 0.00% |
| CLRBCellectar Bioscience... | -0.08 | -4.79% |
| XBIOXenetic Biosciences ... | +0.24 | +9.88% |
| HTBXHeat Biologics Inc | -0.00 | -0.03% |
Data as of 3:59pm ET, 06/26/2017
Financials
| Last reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$11.4M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Michael R. Bristow |
Chief Operating Officer Thomas A. Keuer |
Corporate headquarters Westminster, Colorado |
Forecasts
